https://scholars.lib.ntu.edu.tw/handle/123456789/521445
標題: | Initial experience with ABO-incompatible live donor renal transplantation | 作者: | MENG-KUN TSAI Wu M.-H. SHYH-CHYI LO I-RUE LAI Yu S.-C. RAY-HWANG YUAN PO-HUANG LEE |
公開日期: | 2006 | 出版社: | Scientific Communications International Ltd | 卷: | 105 | 期: | 9 | 起(迄)頁: | 775-779 | 來源出版物: | Journal of the Formosan Medical Association | 摘要: | The serious shortage of cadaveric organs has prompted the development of ABO-incompatible live donor renal transplantation. We report our experience of the initial two live donor ABO incompatible renal transplants at our hospital. The first patient was a 55-year-old type A female who received a kidney from her AB type husband. The second patient was a 27-year-old type O male who received renal transplantation from his type A father. Preconditioning immunosuppressive therapy in the two patients with tacrolimus, mycophenolate mofetil and methylprednisolone was started 7 days before transplantation. During the period of preconditioning, double filtration plasmapheresis (DFPP) was employed to remove anti-A and -B antibodies. Laparoscopic splenectomy and renal transplantation were performed after the anti-donor ABO antibodies were reduced to a titer of 1:4. Rituximab, a humanized monoclonal anti- CD20 antibody, was administered to the second patient due to a rebound in the anti-A antibody titer during the preconditioning period. Under a tacrolimus-based immunosuppressive regimen, both patients recovered very well without any evidence of rejection. Serum creatinine levels were 1.0 and 1.4 mg/dL at 6 and 3 months after transplantation, respectively. These cases illustrate that with new immunosuppressive agents, DFPP and splenectomy, ABO-incompatible renal transplantation can be successfully conducted in end-stage renal disease patients whose only available live donors are blood group incompatible. ? 2006 Elsevier & Formosan Medical Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749360087&doi=10.1016%2fS0929-6646%2809%2960208-4&partnerID=40&md5=1d23039e0a3b200be39df9ac20fb141a https://scholars.lib.ntu.edu.tw/handle/123456789/521445 |
ISSN: | 0929-6646 | DOI: | 10.1016/S0929-6646(09)60208-4 | SDG/關鍵字: | creatinine; fresh frozen plasma; glucose; hemoglobin; methylprednisolone; mycophenolic acid 2 morpholinoethyl ester; nitrogen; prednisolone; rapamycin; rapaume; rituximab; tacrolimus; unclassified drug; urea; adult; antibody titer; article; blood cell count; blood clotting disorder; blood group AB; blood group ABO incompatibility; case report; chronic kidney failure; clinical feature; continuous infusion; creatinine blood level; dose response; drug dose reduction; drug substitution; epigastric pain; female; glucose blood level; hemoglobin determination; HLA system; human; immunological monitoring; immunosuppressive treatment; kidney transplantation; laboratory test; laparoscopic surgery; leukocyte count; liver function test; living donor; lymphocyte depletion; male; nephrectomy; physical examination; plasmapheresis; postoperative period; recipient; splenectomy; thrombocyte count; treatment outcome; urea nitrogen blood level; vomiting |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。